Gufic Biosciences Limited has informed the Exchange regarding Change in Auditors of the company.
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gufic Biosciences' Board of Directors has approved two auditor appointments at its meeting on May 29, 2026. The company re-appointed M/s. Poddar & Co., Cost Accountants as Cost Auditors for Financial Year 2026-27. Additionally, Mrs. Saroj R. Kirdolia, a Chartered Accountant with 7+ years of experience including 6 years with the company, has been appointed as Internal Auditor for FY 2026-27. The Cost Auditor is a statutory requirement while the Internal Auditor will evaluate internal controls and business processes. Both appointments are routine governance matters with standard terms.
These are routine auditor appointments and do not indicate any accounting concerns or governance issues. The re-appointment of an existing cost auditor and hiring of a familiar internal auditor suggests stable financial oversight. Shareholders should view this positively as it reflects normal operational governance.